サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1109457

サル痘診断薬の世界市場：アッセイ別、国別、製品別、地域別 - エグゼクティブコンサルタントガイド、市場分析と予測（2022年～2026年）

MONKEYPOX DIAGNOSTICS Global Markets by Assay, by Country, by Product, and by Place. With Executive and Consultant Guides and Market Analysis and Forecasts 2022 - 2026
出版日: | 発行: Howe Sound Research | ページ情報: 英文 294 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
サル痘診断薬の世界市場：アッセイ別、国別、製品別、地域別 - エグゼクティブコンサルタントガイド、市場分析と予測（2022年～2026年）
出版日: 2022年08月04日
発行: Howe Sound Research
ページ情報: 英文 294 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

サル痘は健康上の緊急事態として宣言されています。最新のデータでは、アフリカ以外の地域への流行が驚くべきスピードで拡大しています。世界中の政府は、この脅威を未然に防ぐため、広範な検査を実施する準備を進めています。体外診断薬業界にはビジネスチャンスがあふれています。

当レポートでは、2026年までの市場規模を予測しています。成長は基本的な要因からもたらされますが、COVIDパンデミックは現在および予測可能な将来にわたって市場の状況を変化させています。一部のプレーヤーはすでに頭角を現していますが、破壊的な診断技術により、競争の場が変わる可能性があります。この市場について、課題、展望を含めてご紹介します。迅速診断とゲノミクス革命という2つの主要トレンドが融合し、新たな診断機会を創出しています。

すべてのレポートデータは、ご要望に応じてエクセル形式でご提供します。

最新のデータを用いて、自信を持って投資判断や評価を下すことができます。

当レポートでは、世界のサル痘診断薬市場について調査し、市場の概要とともに、アッセイ別、国別、製品別、場所別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

  • サル痘診断薬の概要
    • 2022年のアウトブレイク
  • 市場の定義
  • 調査手法
  • ヘルスケアと体外診断薬業界

第3章 サル痘-現在の科学

  • サル痘とは何か
  • アウトブレイク
  • 感染
  • 徴候と症状
  • 診断
  • 治療
  • サル痘と天然痘の関係

第4章 業界概要

  • ダイナミックな市場における参入企業
    • 学術研究機関
    • 診断試験開発業者
    • 医薬品/試薬サプライヤー
    • 独立系試験所
    • 公共の国立/地域の研究所
    • 院内検査室
    • 診療所検査室
    • 監査機関
    • 認証機関

第5章 市場動向

  • 成長促進要因
  • 成長阻害要因
  • 診断技術開発

第6章 サル痘の診断- 最近の発展

第7章 主要企業のプロファイル

  • Abbott Diagnostics
  • Aegis Laboratories
  • Applied DNA Sciences
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BioGX
  • bioMérieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • CerTest Biotec
  • Creative Biogene
  • Flow Health
  • Labcorp
  • Mayo Clinic Laboratories
  • Quest Diagnostics
  • Qiagen Gmbh
  • Roche Molecular Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Sysmex
  • Thermo Fisher Scientific Inc.

第8章 世界のサル痘診断薬市場の概要

  • 国別
  • アッセイ別
  • 製品別
  • 場所別

第9章 世界のサル痘診断薬市場-アッセイ別

  • PCR
  • NGS
  • 迅速試験
  • その他のアッセイ
  • バイオマーカー

第10章 世界のサル痘診断薬市場-製品別

  • 装置
  • 消耗品
  • ソフトウェアとサービス

第11章 世界のサル痘診断薬市場-場所別

  • 病院
  • クリニック/POL
  • その他

第12章 付録

図表

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Five Factors Driving Growth
  • Table 3: Three Factors Limiting Growth
  • Table 4: Global Monkeypox Diagnostics Market by Country/Region
  • Table 5: Global Market by Assay
  • Table 7: Global Market by Product
  • Table 9: Global Market by Place
  • Table 1: Monkeypox Diagnostic PCR by Country
  • Table 1: Monkeypox Diagnostic NGS by Country
  • Table 13: Monkeypox Diagnostic Rapid by Country
  • Table 14: Monkeypox Diagnostic Other Assay by Country
  • Table 15: Monkeypox Diagnostic Biomarker Other by Country
  • Table 21: Monkeypox Diagnostic Instrumentation by Country
  • Table 22: Monkeypox Diagnostic Consumables by Country
  • Table 23: Monkeypox Diagnostic Software & Service by Country
  • Table 26: Monkeypox Diagnostic Hospital by Country
  • Table 26: Monkeypox Diagnostic Clinic/POL by Country
  • Table 27: Monkeypox Diagnostic Other Place by Country
  • Table 28: 2022 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Percentage of Patients with Comorbidity
  • Figure 2: Global Healthcare Spending Map
  • Figure 3: The Lab Test Pie - Wholesale and Retail
  • Figure 4: Deaths From Drug Resistant Infections 2050
  • Figure 5: Aggregate Age of World Population
  • Figure 6: Growth in Health Care Spending Developing World
  • Figure 7: Comparing The New Diagnostics and Traditional Testing
  • Figure 8: Global Market Share Chart
  • Figure 9: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 10: Monkeypox Diagnostics Market by Assay Base Year
  • Figure 11: Monkeypox Diagnostics Market by Assay Final Year
  • Figure 15: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 16: Monkeypox Diagnostics Market by Product Base Year
  • Figure 17: Monkeypox Diagnostics Market by Product Final Year
  • Figure 21: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 22: Monkeypox Diagnostics Market by Place Base Year
  • Figure 23: Monkeypox Diagnostics Market by Place Final Year
  • Figure 25: MONKEYPOX Diagnostics Syndromic POC Panel Growth
  • Figure 26: Monkeypox Diagnostic NGS Growth
  • Figure 27: Monkeypox Diagnostic Rapid Growth
  • Figure 28: Monkeypox Diagnostic Other Assay Growth
  • Figure 29: Monkeypox Diagnostic Biomarker Other Growth
  • Figure 35: Monkeypox Diagnostic Instrumentation Growth
  • Figure 36: MONKEYPOX Diagnostics Consumables
  • Figure 37: Monkeypox Diagnostic Software & Service Growth
  • Figure 40: Monkeypox Diagnostic GastroIntestinal Growth
  • Figure 40: Monkeypox Diagnostic Clinic/POL Growth
  • Figure 41: MONKEYPOX Diagnostics Other Place
目次

OVERVIEW:

Monkeypox is being declared a health emergency. Latest data show the outbreak into non-African regions is expanding at alarming rates. Governments around the world are preparing to use widespread testing to get in front of this threat from the beginning. Opportunities abound for the In Vitro Diagnostic Industry.

The report forecasts the market size out to 2026. Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnostics and the Genomics Revolution are merging to create new diagnostic opportunities.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. An Overview of Monkeypox Diagnostics
    • 2.1.1. The 2022 Outbreak
  • 2.2. Market Definition
    • 2.2.1. Market Size
    • 2.2.2. Currency
    • 2.2.3. Years
    • 2.2.4. PCR
    • 2.2.5. NGS
    • 2.2.6. Syndromic PoC
    • 2.2.7. Biomarkers Molecular Diagnostics
    • 2.2.8. Biomarkers Other
    • 2.2.9. Limitations
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Monkeypox-Current Science

  • 3.1. What is Monkeypox?
  • 3.2. Outbreaks
  • 3.3. Transmission
  • 3.4. Signs and symptoms
  • 3.5. Diagnosis
  • 3.6. Therapeutics
    • 3.6.1. Vaccination
    • 3.6.2. Prevention
  • 3.6.2.1. Reducing the risk of human-to-human transmission
  • 3.6.2.2. Reducing the risk of zoonotic transmission
  • 3.7. How monkeypox relates to smallpox

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Diagnostic Test Developer
    • 4.1.3. Pharmaceutical/Reagent Supplier
    • 4.1.4. Independent Testing Lab
    • 4.1.5. Public National/regional lab
    • 4.1.6. Hospital lab
    • 4.1.7. Physician Lab
    • 4.1.8. Audit Body
    • 4.1.9. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Prevalence
    • 5.1.2. Surveillance
    • 5.1.3. Pandemic Wind Down
    • 5.1.4. Viral Zeitqeist
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve Shrinks the Market
    • 5.2.2. Transmission Outlook
    • 5.2.3. Adoption Lag and Cost Control
  • 5.3. Diagnostic Technology Development
    • 5.3.1. The Multiplex Opportunity
    • 5.3.2. Shifting Role of Physicians in Diagnosis
    • 5.3.3. Diagnostics Moves Out of the Lab
    • 5.3.4. Biomarkers and Algorithms
    • 5.3.5. Rapid Testing Changing Medical Practice
    • 5.3.6. Genome Role and Big Data

6. Monkeypox Diagnostics - Recent Developments

  • 6.1. Recent Developments-Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. U.S. to declare monkeypox a public health emergency
  • 6.3. BioGX Gets CE-IVD Mark for Multigene POC Test
  • 6.4. World Health Organization declares monkeypox a global emergency
  • 6.5. Quest Begins Offering Internally Developed Monkeypox Test
  • 6.6. CDC, Abbott, Roche, BioMérieux Get FDA 510(k) Clearances
  • 6.7. Commercial, Academic Labs Ramp Up Monkeypox Testing
  • 6.8. Becton Dickinson, CerTest Biotec Collaborate on Monkeypox MDx
  • 6.9. Sequence Coming In

7. Profiles of Key Companies

  • 7.1. Abbott Diagnostics
  • 7.2. Aegis Laboratories
  • 7.3. Applied DNA Sciences
  • 7.4. Beckman Coulter Diagnostics
  • 7.5. Becton, Dickinson and Company
  • 7.6. BioGX
  • 7.7. bioMérieux Diagnostics
  • 7.8. Bio-Rad Laboratories, Inc.
  • 7.9. Cepheid
  • 7.10. CerTest Biotec
  • 7.11. Creative Biogene
  • 7.12. Flow Health
  • 7.13. Labcorp
  • 7.14. Mayo Clinic Laboratories
  • 7.15. Quest Diagnostics
  • 7.16. Qiagen Gmbh
  • 7.17. Roche Molecular Diagnostics
  • 7.18. Siemens Healthineers
  • 7.19. Sonic Healthcare
  • 7.20. Sysmex
  • 7.21. Thermo Fisher Scientific Inc.

8. Monkeypox Global Diagnostic Markets Overview

  • 8.1. Monkeypox Diagnostics-Global Market Overview by Country
    • 8.1.1. Table-Global Market by Country
    • 8.1.2. Chart - Global Market by Country
  • 8.2. Global Monkeypox Diagnostics Markets Overview by Assay
    • 8.2.1. Table-Global Market by Assay
    • 8.2.2. Chart-Global Market by Assay-Segments Growth
    • 8.2.3. Chart-Global Market by Assay-Share by Year
    • 8.2.4. Chart-Global Market by Assay
    • 8.2.5. Chart-Global Market by Assay-Base Year
    • 8.2.6. Chart-Global Market by Assay-Final Year
  • 8.3. Global Monkeypox Diagnostics Markets Overview by Product
    • 8.3.1. Table-Global Market by Product
    • 8.3.2. Chart-Global Market by Product-Segments Growth
    • 8.3.3. Chart-Global Market by Product-Share by Year
    • 8.3.4. Chart-Global Market by Product
    • 8.3.5. Chart-Global Market by Product-Base Year
    • 8.3.6. Chart-Global Market by Product-Final Year
  • 8.4. Global Monkeypox Diagnostics Markets Overview by Place
    • 8.4.1. Table-Global Market by Place
    • 8.4.2. Chart-Global Market by Place-Segments Growth
    • 8.4.3. Chart-Global Market by Place-Share by Year
    • 8.4.4. Chart-Global Market by Place
    • 8.4.5. Chart-Global Market by Place-Base Year
    • 8.4.6. Chart-Global Market by Place-Final Year

9. Monkeypox Diagnostic Market-by Assay

  • 9.1. Monkeypox Diagnostic - PCR
    • 9.1.1. Table Monkeypox Diagnostic PCR-by Country
    • 9.1.2. Chart - Monkeypox Diagnostic PCR Growth
  • 9.2. Monkeypox Diagnostic-NGS
    • 9.2.1. Table Monkeypox Diagnostic NGS-by Country
    • 9.2.2. Chart - Monkeypox Diagnostic-NGS Growth
  • 9.3. Monkeypox Diagnostic-Rapid
    • 9.3.1. Table Monkeypox Diagnostic Rapid-by Country
    • 9.3.2. Chart - Monkeypox Diagnostic-Rapid Growth
  • 9.4. Monkeypox Diagnostic-Other Assay
    • 9.4.1. Table Monkeypox Diagnostic Other Assay-by Country
    • 9.4.2. Chart - Monkeypox Diagnostic-Other Assay Growth
  • 9.5. Monkeypox Diagnostic-Biomarker Other
    • 9.5.1. Table Monkeypox Diagnostic Biomarker Other-by Country
    • 9.5.2. Chart - Monkeypox Diagnostic-Biomarker Other Growth

10. Global Monkeypox Diagnostics Markets-By Product

  • 10.1. Monkeypox Diagnostic - Instrumentation
    • 10.1.1. Table Monkeypox Diagnostic Instrumentation-by Country
    • 10.1.2. Chart - Monkeypox Diagnostic Instrumentation Growth
  • 10.2. Monkeypox Diagnostic-Consumables
    • 10.2.1. Table Monkeypox Diagnostic Consumables-by Country
    • 10.2.2. Chart - Monkeypox Diagnostic Consumables
  • 10.3. Monkeypox Diagnostic-Software & Service
    • 10.3.1. Table Monkeypox Diagnostic Software & Service-by Country
    • 10.3.2. Chart - Monkeypox Diagnostic-Software & Service Growth

11. Global Monkeypox Diagnostics Markets-By Place

  • 11.1. Monkeypox Diagnostic - Hospital
    • 11.1.1. Table Monkeypox Diagnostic Hospital-by Country
    • 11.1.2. Chart - Monkeypox Diagnostic Hospital Growth
  • 11.2. Monkeypox Diagnostic-Clinic/POL
    • 11.2.1. Table Monkeypox Diagnostic Clinic/POL-by Country
    • 11.2.2. Chart - Monkeypox Diagnostic Clinic/POL Growth
  • 11.3. Monkeypox Diagnostic-Other Place
    • 11.3.1. Table Monkeypox Diagnostic Other Place-by Country
    • 11.3.2. Chart - Monkeypox Diagnostic Other Place

12. Appendices

  • 12.1. United States Medicare System: 2022 Clinical Laboratory Fees Schedule